文献速递临床试验与 GCP真实世界研究与卫生经济

减少缺血性心脏病患者感知压力的移动健康干预:随机对照确证性干预试验「mStress-IHD」的研究方案

A mHealth intervention to reduce perceived stress in patients with ischemic heart disease: study protocol of the randomized, controlled confirmatory intervention "mStress-IHD" trial.
PubMed 文献 · Trials · 2023-09-15

针对缺血性心脏病(IHD)患者压力高发且压力管理未常规实施的问题,本研究为随机对照确证性干预试验,评估移动健康干预「mindfulHeart」降低压力的效果与成本效果。计划纳入128例确诊IHD、高感知压力且使用联网智能手机的患者,随机分为干预组与对照组,在基线、治疗后及干预后1、3、6、12个月共6个时间点评估,主要分析采用意向性治疗人群的协方差分析。

要点

  • IHD患者压力高发,与健康相关生活质量降低和心血管结局受损相关。
  • 试验评估mHealth干预「mindfulHeart」降低IHD患者压力的效果与成本效果。
  • 计划纳入128例,随机分干预组与对照组,主要分析采用意向性治疗人群的协方差分析。

核心结论

  • 该试验旨在评估mHealth干预「mindfulHeart」在降低IHD患者压力方面的效果与成本效果。

研究设计与样本

  • 随机对照确证性干预试验,两平行组,在基线(T0,随机化前)、治疗后(T1)及干预后1、3、6、12个月(T2、T3、T4、T5)共6个时间点评估。
  • 纳入确诊IHD、高感知压力且使用联网智能手机的患者,随机分为干预组与对照组。
  • 计划样本量共128例,主要分析在意向性治疗人群中进行并对缺失数据插补。

主要发现

  • 主要分析采用协方差分析,以T1结局为因变量,组别(干预组 vs 对照组)为组间因素,参与者干预前基线值为协变量。
  • 次要分析采用不同的方差分析、回归和描述性方法。

关键数值与推荐

  • 杜伊斯堡-埃森大学医学院伦理委员会批准该研究(22-11,015-BO)。
  • 试验注册号ClinicalTrials NCT05846334,发布日期2023年4月26日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stress is highly prevalent in patients with ischemic heart disease (IHD) and is associated with lower health-related quality of life and impaired cardiovascular outcome. The importance of stress management is now recognized in recent guidelines for the management of cardiovascular disease. However, effective stress management interventions are not implemented in clinical routine yet. The development of easily disseminated eHealth interventions, particularly mHealth, may offer a cost-effective and scalable solution to this problem. The aim of the proposed trial is to assess the efficiency and cost-effectiveness of the mHealth intervention "mindfulHeart" in terms of reducing stress in patients with IHD. METHODS AND ANALYSIS: This randomized controlled confirmatory interventional trial with two parallel arms has assessments at six measurement time points: baseline (T0, prior randomization), post-treatment (T1), and four follow-ups at months 1, 3, 6, and 12 after intervention (T2, T3, T4, and T5). We will include patients with confirmed diagnosis of IHD, high-perceived stress, and use of an internet-enabled smartphone. Patients will be randomized into two groups (intervention vs. control). The proposed sample size calculation allocates 128 participants in total. The primary analysis will be performed in the intention-to-treat population, with missing data imputed. An ANCOVA with the outcome at T1, a between-subject factor (intervention vs. control), and the participants' pre-intervention baseline values as a covariate will be used. Different ANOVAs, regression, and descriptive approaches will be performed for secondary analyses. ETHICS: The Ethics Committee of the Medical Faculty of the University of Duisburg-Essen approved the study (22-11,015-BO). TRIAL REGISTRATION: ClinicalTrials NCT05846334. Release 26.04.2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lortz J, Rassaf T, Jansen C, et al. A mHealth intervention to reduce perceived stress in patients with ischemic heart disease: study protocol of the randomized, controlled confirmatory intervention "mStress-IHD" trial. Trials. 2023. PMID: 37715203. doi:10.1186/s13063-023-07618-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。